Stefan Duensing
Overview
Explore the profile of Stefan Duensing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
3144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schutz V, Nessler C, Duensing A, Zschabitz S, Jager D, Debus J, et al.
Front Oncol
. 2024 Dec;
14:1475914.
PMID: 39720562
Background And Objectives: The standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC) includes androgen deprivation therapy (ADT), novel antihormonal therapies (NHT) and/or chemotherapy. Patients with newly diagnosed...
2.
Glemser P, Freitag M, Kovacs B, Netzer N, Dimitrakopoulou-Strauss A, Haberkorn U, et al.
EJNMMI Rep
. 2024 Nov;
8(1):37.
PMID: 39510993
Background: To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in...
3.
Huber A, Kaczorowski A, Schneider F, Boning S, Gortz M, Langhoff D, et al.
Sci Rep
. 2024 Aug;
14(1):20281.
PMID: 39217197
Prostate cancer is characterized by a high degree of intratumoral heterogeneity. However, little is known about the spatial distribution of cancer cells with respect to specific functional characteristics and the...
4.
Kippenberger M, Schonberg G, Kaczorowski A, Schneider F, Boning S, Sun A, et al.
Urol Oncol
. 2024 Jul;
42(11):373.e9-373.e17.
PMID: 38981801
Introduction: Clear cell Renal Cell Carcinoma (ccRCC) has a poor prognosis once metastatic. However, certain metastatic sites have been reported to have a different impact on the patient prognosis. For...
5.
Reimold P, Tosev G, Kaczorowski A, Friedhoff J, Schwab C, Schutz V, et al.
Diagnostics (Basel)
. 2024 Apr;
14(7).
PMID: 38611655
Background: Renal cell carcinoma (RCC) is among the most lethal urologic malignancies once metastatic. Current treatment approaches for metastatic RCC (mRCC) involve immune checkpoint inhibitors (ICIs) that target the PD-L1/PD-1...
6.
Pfeffer T, Krug S, Kracke T, Schurfeld R, Colbatzky F, Kirschner P, et al.
Acta Physiol (Oxf)
. 2024 Mar;
240(4):e14126.
PMID: 38517248
Aim: Although of potential biomedical relevance, dipeptide metabolism has hardly been studied. We found the dipeptidase carnosinase-2 (CN2) to be abundant in human proximal tubules, which regulate water and solute...
7.
Schutz V, Lin H, Kaczorowski A, Zschabitz S, Jager D, Stenzinger A, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136261
Metastatic renal cell carcinoma (RCC) is among the most lethal urological malignancies. However, small, localized RCCs (≤7 cm, stage T1) have an excellent prognosis. There is a rare patient subgroup...
8.
Schneider F, Kaczorowski A, Jurcic C, Kirchner M, Schwab C, Schutz V, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894418
Clear cell renal cell carcinoma (ccRCC) is characterized by a high degree of intratumoral heterogeneity (ITH). Besides genomic ITH, there is considerable functional ITH, which encompasses spatial niches with distinct...
9.
Gau D, Daoud A, Allen A, Joy M, Sagan A, Lee S, et al.
J Biol Chem
. 2023 Jul;
299(8):105044.
PMID: 37451478
Overexpression of actin-binding protein profilin-1 (Pfn1) correlates with advanced disease features and adverse clinical outcome of patients with clear cell renal carcinoma, the most prevalent form of renal cancer. We...
10.
Mikuteit M, Zschabitz S, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
Urol Int
. 2023 Jun;
107(7):713-722.
PMID: 37348477
Introduction: Growth arrest-specific protein 6 (Gas 6) is a ligand that plays a role in proliferation and migration of cells. For several tumor entities, high levels of Gas 6 are...